Surmodics has announced the establishment of Surmodics Services & Technologies, a new division aimed at preserving the legacy of Biocoat. This initiative follows the merger between Surmodics and Biocoat, which involved the divestiture of certain assets. The newly formed division will retain core operations from Biocoat that were not sold, allowing it to operate under a distinct identity within the Surmodics organization.
Focus on Customer-Centric Development
Based in Horsham, Pennsylvania, Surmodics Services & Technologies is set to provide advanced hydrophilic and specialty coating technologies. The division will also offer comprehensive development and engineering services to medical device manufacturers globally. Company officials emphasized that the division is designed to function as a customer-focused organization, fostering close collaboration with device makers throughout the entire product lifecycle.
The Project Development and Engineering team within the new division boasts decades of experience, enabling it to support projects from early-stage concepts to full commercial production. This breadth of expertise positions the division as a key partner in medical device innovation.
Comprehensive Services for Diverse Clients
The Horsham facility offers scalable capabilities that cater to a wide range of clients, including start-ups, contract manufacturers, and large original equipment manufacturers. Services encompass formulation development, feasibility testing, process optimization, and high-volume coating production. This comprehensive service offering positions Surmodics Services & Technologies as an end-to-end partner for medical device development.
In a statement regarding the launch, Chip Hance, CEO of Surmodics, remarked, “Today marks a significant milestone for our organization and for the customers we serve.” He highlighted that the new division reflects a commitment to agility, innovation, and scientific expertise, while maintaining a close partnership with medical device manufacturers.
Surmodics Services & Technologies is poised to play a crucial role in supporting the next generation of medical devices. As manufacturers increasingly seek reliable partners capable of accelerating development while adhering to stringent performance and quality standards, this new division aims to meet those demands effectively.
With this strategic move, Surmodics reinforces its dedication to advancing medical technology, ensuring that it remains a vital player in the industry.